We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| 3D Diagnostic | LSE:3DD | London | Ordinary Share | IM00B3VVCM89 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.175 | - | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 26/1/2011 07:12 | On the day we have NEWS ADVFN isnt functioning properly so we cant read it, at least not yet. | ant15 | |
| 14/12/2010 13:31 | Would be about time for some news?! | tadska | |
| 22/11/2010 21:06 | New to AIM today with a significant premium to placing price of 6p | knowing | |
| 22/11/2010 08:24 | 3D Diagnostic Imaging PLC debut on AIM today having moved up from Plus Markets The company owns IP that it is currently applying to the Dental Market its product Cariescan Pro. The Device has been developed and FDA approval gained to enable its product to be sold into the North American Market and Canada by Pattersons one of the largest Dental wholesalers in the United States.Apart from the detection of early stage Caries in teeth The ACIST Technology developed by Dundee and St Andrews Univerities has a multitude of potential applications not least The detection of very early stage Osteoporosis.A Recent Broker report suggests that the current value of the company is circa £30 million plus. | ant15 |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
